Patients with moderate to severe and severe stroke (NIHSS 16–42) presented with lower TRAIL levels than patients with minor to moderate stroke (73.1 pg/mL vs. 51.3 pg/mL, p = 0.003) (Figure 2a). Here, TNFSF10 is linked to stroke disorder.